The only extended-release bupropion with more than 15 years of experience in MDD and more than 10 years of experience in SAD.
Clinical experience in major depressive disorder (MDD)1,2
Clinical experience in seasonal affective disorder (SAD)1,3
Only the WELLBUTRIN XL brand of bupropion HCl offers once-daily dosing with patented SmartCoatTM technology for consistent around-the-clock coverage.1,4-6
With the Copay Savings Program, eligible* patients pay as little as $5 at their local pharmacy for a 30-day supply.
*Subject to certain limitations.
Get your patients started on WELLBUTRIN XL in the office with free samples.
You are solely responsible for your interactions with that website.
WELLBUTRIN XL® (bupropion hydrochloride extended-release tablets) is indicated for the treatment of major depressive disorder (MDD), and for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (SAD). Periodically reevaluate long-term usefulness for the individual patient.
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
SUICIDALITY AND ANTIDEPRESSANT DRUGS:
Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term trials. These trials did not show an increase in the risk of suicidal thoughts and behavior with antidepressants use in subjects aged 65 and older.
In patients of all ages who are started on antidepressant therapy, monitor closely for worsening, and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber.
To report SUSPECTED ADVERSE REACTIONS, contact Valeant Pharmaceuticals North America LLC at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Click here for full Prescribing Information including Boxed Warning regarding suicidal thoughts and behaviors.
The information contained in this site is technical in nature and was designed specifically for healthcare professionals.
To proceed, please choose one of the following: